Inhaled Beta-2 Agonist Salbutamol for the Treatment of Transient Tachypnea of the Newborn


Armangil D., Yurdakok M., Korkmaz A., Yigit Ş., Tekinalp G.

JOURNAL OF PEDIATRICS, vol.159, no.3, pp.398-404, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 159 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.1016/j.jpeds.2011.02.028
  • Journal Name: JOURNAL OF PEDIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.398-404
  • Hacettepe University Affiliated: Yes

Abstract

Objective To evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the treatment of transient tachypnea of the newborn (TTN) and to determine whether inhaled salbutamol is safe in newborn infants.